A Safety and Tolerability Study of JNJ-42160443 in Patients With Moderate to Severe, Chronic Knee Pain From Osteoarthritis

NCT01094262 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

196

Enrollment

INDUSTRY

Sponsor class

Stopped Logistic reasons associated with the FDA-imposed clinical hold.

Conditions

Osteoarthritis
Osteoarthritis, Knee
Pain
Arthralgia
Joint Pain

Interventions

DRUG: Oxycodone CR (standard pain medication)
DRUG: JNJ-42160443
DRUG: JNJ-42160443
DRUG: Placebo

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.